Skip to content

Effect of yoga on recovery after heart surgery.

Efficacy of yoga based cardiac rehabilitation on clinical outcomes in post CABG patients: A randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/10/009981
Enrollment
300
Registered
2017-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- CORONARY ARTERY BYPASS GRAFTING(CABG)

Interventions

Intervention1: YOGA: Yoga+ conventional medical management which includes physiotherapy, life style modifications and medications. Yoga practices will be taught at AIIMS at baseline, 6 weeks, 3 mont

Sponsors

MINISTRY OF AYUSH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing and able to participate 2. All adults between 35- 65 years of age 3. Patients established with double or triple vessel disease planned for elective CABG d.Patients with uncomplicated peri-operative course, who are able to perform yoga

Exclusion criteria

Exclusion criteria: a. Emergency CABG b. CABG with valve replacement surgeries c. LVEF d. Acute and Chronic renal failure with or without dialysis e. Regular yoga practitioners f. Physical disabilities precluding yoga practice. g. Neuro-psychiatric illness h. Patients already exposed to yoga

Design outcomes

Primary

MeasureTime frame
1.Clinical outcomes Risk factor control: Blood pressure,Glycemic control-( hba1c),Lipid profile,Measurement of obesity- Waist Hip Ratio and BMI,Physical activity- IPAQ Neuropsychiatric outcomes: Anxiety and depresion(Hospital Anxiety and depression Scale), Quality of life- (SF-36 QOL) 2.Rehabilitative outcomes- Exercise capacity ( Modified Bruce potocol) Pulmonary capacity (Pulmonary function test) Timepoint: 6 weeks, 3, 6 and 12 months

Secondary

MeasureTime frame
SECONDARY OUTCOMES 1. MACCE( major adverse cerebrovascular or cardiovascular events) 2. Inflammatory Markers- hs- CRP, IL-6, TNF-a 3. LV- Dysfunction- ECHO 4. Global gene expressionTimepoint: 6 weeks, 3, 6 and 12 months

Countries

India

Contacts

Public ContactDR GAUTAM SHARMA

ALL INDIA INSTITUTE OF MEDICAL SCIENCES

drgautamsharma12@gmail.com01126593862

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026